1. External validation and comparison of IPI, R-IPI, and NCCN-IPI in diffuse large B-cell lymphoma patients treated with R-CHOP to predict 2-year progression-free survival. Issue 1 (31st December 2022) Authors: Warnnissorn, Naree; Kanitsap, Nonglak; Niparuck, Pimjai; Boonsakan, Paisarn; Kulalert, Prapasri; Limvorapitak, Wasithep; Bhoopat, Lantarima; Saengboon, Supawee; Chantrathammachart, Pichika; Puavilai, Teeraya; Chuncharunee, Suporn Journal: Hematology Issue: Volume 27:Issue 1(2022) Page Start: 1237 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗